FDA Approved: LAMOTRIGINE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

The FDA approved Advagen Pharma Limited's supplemental application for lamotrigine, confirming approval of the requested changes to this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)